Search Results - Celia C. Labranche

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site. by Nathanael P McCurley, Arban Domi, Rahul Basu, Kevin O Saunders, Celia C LaBranche, David C Montefiori, Barton F Haynes, Harriet L Robinson

    Published in PLoS ONE (2017-01-01)
    Get full text
    Article


  2. 2

    CTLA-4 Blockade, during HIV Virus-Like Particles Immunization, Alters HIV-Specific B-Cell Responses by Phoebe E. Lewis, Ethan C. Poteet, Dongliang Liu, Changyi Chen, Celia C. LaBranche, Sherry A. Stanfield-Oakley, David C. Montefiori, Guido Ferrari, Qizhi Yao

    Published in Vaccines (2020-06-01)
    Get full text
    Article


  3. 3

    Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity by Seth H. Pincus, Ryan B. Craig, Lauren Weachter, Celia C. LaBranche, Rafiq Nabi, Connie Watt, Mark Raymond, Tami Peters, Kejing Song, Grace A. Maresh, David C. Montefiori, Pamela A. Kozlowski

    Published in Vaccines (2021-07-01)
    Get full text
    Article


  4. 4

    Adjuvants influence the maturation of VRC01-like antibodies during immunization by Maria L. Knudsen, Parul Agrawal, Anna MacCamy, K. Rachael Parks, Matthew D. Gray, Brittany N. Takushi, Arineh Khechaduri, Kelsey R. Salladay, Rhea N. Coler, Celia C. LaBranche, David Montefiori, Leonidas Stamatatos

    Published in iScience (2022-11-01)
    Get full text
    Article


  5. 5

    HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers. by Silvia Capucci, Edmund G Wee, Torben Schiffner, Celia C LaBranche, Nicola Borthwick, Albert Cupo, Jonathan Dodd, Hansi Dean, Quentin Sattentau, David Montefiori, Per J Klasse, Rogier W Sanders, John P Moore, Tomáš Hanke

    Published in PLoS ONE (2017-01-01)
    Get full text
    Article


  6. 6

    Correction: HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers. by Silvia Capucci, Edmund G Wee, Torben Schiffner, Celia C LaBranche, Nicola Borthwick, Albert Cupo, Jonathan Dodd, Hansi Dean, Quentin Sattentau, David Montefiori, Per J Klasse, Rogier W Sanders, John P Moore, Tomáš Hanke

    Published in PLoS ONE (2023-01-01)
    Get full text
    Article


  7. 7

    Detection of HIV-1 neutralizing antibodies in a human CD4⁺/CXCR4⁺/CCR5⁺ T-lymphoblastoid cell assay system. by Robert J McLinden, Celia C Labranche, Agnès-Laurence Chenine, Victoria R Polonis, Michael A Eller, Lindsay Wieczorek, Christina Ochsenbauer, John C Kappes, Stephen Perfetto, David C Montefiori, Nelson L Michael, Jerome H Kim

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  8. 8

    Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvants. by Rachel P J Lai, Michael S Seaman, Paul Tonks, Frank Wegmann, David J Seilly, Simon D W Frost, Celia C LaBranche, David C Montefiori, Antu K Dey, Indresh K Srivastava, Quentin Sattentau, Susan W Barnett, Jonathan L Heeney

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  9. 9

    Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma. by Amit Kumar, Claire E P Smith, Elena E Giorgi, Joshua Eudailey, David R Martinez, Karina Yusim, Ayooluwa O Douglas, Lisa Stamper, Erin McGuire, Celia C LaBranche, David C Montefiori, Genevieve G Fouda, Feng Gao, Sallie R Permar

    Published in PLoS Pathogens (2018-04-01)
    Get full text
    Article


  10. 10

    High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers by Iván del Moral-Sánchez, Rebecca A. Russell, Edith E. Schermer, Christopher A. Cottrell, Joel D. Allen, Alba Torrents de la Peña, Celia C. LaBranche, Sanjeev Kumar, Max Crispin, Andrew B. Ward, David C. Montefiori, Quentin J. Sattentau, Kwinten Sliepen, Rogier W. Sanders

    Published in npj Vaccines (2022-02-01)
    Get full text
    Article


  11. 11

    Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins. by Torben Schiffner, Jesper Pallesen, Rebecca A Russell, Jonathan Dodd, Natalia de Val, Celia C LaBranche, David Montefiori, Georgia D Tomaras, Xiaoying Shen, Scarlett L Harris, Amin E Moghaddam, Oleksandr Kalyuzhniy, Rogier W Sanders, Laura E McCoy, John P Moore, Andrew B Ward, Quentin J Sattentau

    Published in PLoS Pathogens (2018-05-01)
    Get full text
    Article


  12. 12

    Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques by Norbert Pardi, Celia C. LaBranche, Guido Ferrari, Derek W. Cain, István Tombácz, Robert J. Parks, Hiromi Muramatsu, Barbara L. Mui, Ying K. Tam, Katalin Karikó, Patricia Polacino, Christopher J. Barbosa, Thomas D. Madden, Michael J. Hope, Barton F. Haynes, David C. Montefiori, Shiu-Lok Hu, Drew Weissman

    Published in Molecular Therapy: Nucleic Acids (2019-04-01)
    Get full text
    Article


  13. 13

    Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates. by Jelle van Schooten, Marlies M van Haaren, Hui Li, Laura E McCoy, Colin Havenar-Daughton, Christopher A Cottrell, Judith A Burger, Patricia van der Woude, Leanne C Helgers, Ilhan Tomris, Celia C Labranche, David C Montefiori, Andrew B Ward, Dennis R Burton, John P Moore, Rogier W Sanders, Shane Crotty, George M Shaw, Marit J van Gils

    Published in PLoS Pathogens (2021-08-01)
    Get full text
    Article


  14. 14

    Innate protection against intrarectal SIV acquisition by a live SHIV vaccine by Yongjun Sui, Thomas J. Meyer, Christine M. Fennessey, Brandon F. Keele, Kimia Dadkhah, Chi Ma, Celia C. LaBranche, Matthew W. Breed, Josh A. Kramer, Jianping Li, Savannah E. Howe, Guido Ferrari, LaTonya D. Williams, Maggie Cam, Michael C. Kelly, Xiaoying Shen, Georgia D. Tomaras, David Montefiori, Tim F. Greten, Christopher J. Miller, Jay A. Berzofsky

    Published in JCI Insight (2024-06-01)
    Get full text
    Article


  15. 15

    Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection by Srivamshi Pittala, Kenneth Bagley, Jennifer A Schwartz, Eric P Brown, Joshua A Weiner, Ilia J Prado, Wenlei Zhang, Rong Xu, Ayuko Ota‐Setlik, Ranajit Pal, Xiaoying Shen, Charles Beck, Guido Ferrari, George K Lewis, Celia C LaBranche, David C Montefiori, Georgia D Tomaras, Galit Alter, Mario Roederer, Timothy R Fouts, Margaret E Ackerman, Chris Bailey‐Kellogg

    Published in Molecular Systems Biology (2019-05-01)
    Get full text
    Article


  16. 16

    Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques by Venkata S. Bollimpelli, Pradeep B. J Reddy, Sailaja Gangadhara, Tysheena P. Charles, Samantha L. Burton, Gregory K. Tharp, Tiffany M. Styles, Celia C. Labranche, Justin C. Smith, Amit A. Upadhyay, Anusmita Sahoo, Traci Legere, Ayalnesh Shiferaw, Vijayakumar Velu, Tianwei Yu, Mark Tomai, John Vasilakos, Sudhir P. Kasturi, George M. Shaw, David Montefiori, Steven E. Bosinger, Pamela A. Kozlowski, Bali Pulendran, Cynthia A. Derdeyn, Eric Hunter, Rama R. Amara

    Published in Nature Communications (2023-08-01)
    Get full text
    Article


  17. 17

    A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infection. by Scott P Lawrence, Samra E Elser, Workineh Torben, Robert V Blair, Bapi Pahar, Pyone P Aye, Faith Schiro, Dawn Szeltner, Lara A Doyle-Meyers, Beth S Haggarty, Andrea P O Jordan, Josephine Romano, George J Leslie, Xavier Alvarez, David H O'Connor, Roger W Wiseman, Christine M Fennessey, Yuan Li, Michael Piatak, Jeffrey D Lifson, Celia C LaBranche, Andrew A Lackner, Brandon F Keele, Nicholas J Maness, Mark Marsh, James A Hoxie

    Published in PLoS Pathogens (2022-06-01)
    Get full text
    Article


  18. 18

    Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein by Jelle van Schooten, Elinaz Farokhi, Anna Schorcht, Tom L. G. M. van den Kerkhof, Hongmei Gao, Patricia van der Woude, Judith A. Burger, Tim G. Rijkhold Meesters, Tom Bijl, Riham Ghalaiyini, Hannah L. Turner, Jessica Dorning, Barbera D. C. van Schaik, Antoine H. C. van Kampen, Celia C. Labranche, Robyn L. Stanfield, Devin Sok, David C. Montefiori, Dennis R. Burton, Michael S. Seaman, Gabriel Ozorowski, Ian A. Wilson, Rogier W. Sanders, Andrew B. Ward, Marit J. van Gils

    Published in Nature Communications (2022-08-01)
    Get full text
    Article


  19. 19

    Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer. by Jelle van Schooten, Anna Schorcht, Elinaz Farokhi, Jeffrey C Umotoy, Hongmei Gao, Tom L G M van den Kerkhof, Jessica Dorning, Tim G Rijkhold Meesters, Patricia van der Woude, Judith A Burger, Tom Bijl, Riham Ghalaiyini, Alba Torrents de la Peña, Hannah L Turner, Celia C Labranche, Robyn L Stanfield, Devin Sok, Hanneke Schuitemaker, David C Montefiori, Dennis R Burton, Gabriel Ozorowski, Michael S Seaman, Ian A Wilson, Rogier W Sanders, Andrew B Ward, Marit J van Gils

    Published in PLoS Pathogens (2022-11-01)
    Get full text
    Article


Search Tools: